Skip to content

Research paper

Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.

The Cochrane database of systematic reviews
Q1
Jan 2017
Citations: 47
Influential: 1
Systematic Reviews / Meta-Analyses
90

Study answer

What this study found

Overall, evidence was insufficient to show that maternal probiotics during pregnancy or after birth provide clear benefit or harm for preterm infants. When probiotics were given to mothers after birth for preterm infants, there was a potential reduction in time to reach 50% enteral feeds, but the estimate was extremely imprecise. The review did not establish meaningful effects on neonatal morbidity or mortality, and there were no direct data comparing maternal probiotic administration with neonatal probiotic administration. One trial reported reduced maternal mastitis, but the broader…

Study & population
Systematic review and meta-analysis of randomized trials in pregnant women at risk for preterm birth and mothers after delivery of preterm infants, including infants born preterm and very low birth weight infants.
Intervention
Maternal probiotic supplementation was given either during pregnancy or after birth to mothers of preterm infants, compared with placebo or no intervention.
Key limitation
The evidence base was small and heterogeneous, with different probiotic strains, doses, and timing of administration across trials.
View sourceOpen PDF

Original abstract

BACKGROUND Inflammation may contribute to preterm birth and to morbidity of preterm infants. Preterm infants are at risk for alterations in the normal protective microbiome. Oral probiotics administered directly to preterm infants have been shown to …